HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Piero Portincasa Selected Research

Mitochondrial Diseases (Mitochondrial Disease)

7/2022The Potential of the Mediterranean Diet to Improve Mitochondrial Function in Experimental Models of Obesity and Metabolic Syndrome.
1/2022Oxidative stress, aging, antioxidant supplementation and their impact on human health: An overview.
5/2014Pathogenic role of oxidative and nitrosative stress in primary biliary cirrhosis.
1/2013Cardiac mitochondrial dysfunction during hyperglycemia--the role of oxidative stress and p66Shc signaling.
10/2010Nonalcoholic fatty liver disease.
10/2007Mitochondrial dysfunction in rat with nonalcoholic fatty liver Involvement of complex I, reactive oxygen species and cardiolipin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Piero Portincasa Research Topics

Disease

50Gallstones (Gallstone)
10/2023 - 04/2002
35Cholelithiasis
10/2023 - 07/2002
34Non-alcoholic Fatty Liver Disease
04/2024 - 01/2006
24Obesity
02/2024 - 08/2014
24Fatty Liver
08/2023 - 01/2006
21Inflammation (Inflammations)
11/2023 - 01/2006
19Insulin Resistance
10/2023 - 10/2010
16Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2023 - 12/2006
12Fibrosis (Cirrhosis)
10/2023 - 01/2006
12Liver Diseases (Liver Disease)
03/2023 - 09/2006
9Neoplasms (Cancer)
10/2023 - 07/2004
9Metabolic Diseases (Metabolic Disease)
02/2023 - 06/2008
8Liver Cirrhosis (Hepatic Cirrhosis)
03/2023 - 01/2005
7Overweight
10/2023 - 08/2006
7Hepatocellular Carcinoma (Hepatoma)
03/2023 - 06/2011
7COVID-19
01/2023 - 01/2020
7Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
01/2023 - 06/2014
7Cholestasis
11/2022 - 02/2007
6Mitochondrial Diseases (Mitochondrial Disease)
07/2022 - 10/2007
6Abdominal Pain (Pain, Abdominal)
06/2022 - 07/2015
6Alcoholic Fatty Liver
04/2022 - 08/2006
6Infections
01/2021 - 06/2017
5Weight Loss (Weight Reduction)
02/2024 - 08/2014
5Atherosclerosis
08/2023 - 01/2013
4Type 2 Diabetes Mellitus (MODY)
10/2023 - 07/2011
4Dyslipidemias (Dyslipidemia)
08/2023 - 01/2007
4Constipation
01/2021 - 07/2007
4Body Weight (Weight, Body)
09/2019 - 05/2012
4Digestive System Diseases
01/2018 - 01/2012
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2023 - 10/2014
3Portal Hypertension
10/2023 - 03/2010
3Hypertrophy
10/2023 - 01/2019
3Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
02/2023 - 07/2002
3Dysbiosis
06/2022 - 04/2019
3Pancreatitis
01/2022 - 12/2014
3Cardiovascular Diseases (Cardiovascular Disease)
12/2020 - 01/2012
3AIDS-Related Complex (ARC)
02/2019 - 02/2010
3Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
05/2014 - 02/2007
2Malnutrition (Nutritional Deficiencies)
02/2024 - 12/2015
2Inborn Genetic Diseases (Disease, Hereditary)
10/2023 - 02/2015
2Kidney Diseases (Kidney Disease)
10/2023 - 01/2019

Drug/Important Bio-Agent (IBA)

53CholesterolIBA
10/2023 - 04/2002
24LipidsIBA
10/2023 - 03/2003
18Bile Acids and Salts (Bile Acids)IBA
11/2023 - 03/2003
12Fatty Acids (Saturated Fatty Acids)IBA
10/2023 - 01/2012
12Proteins (Proteins, Gene)FDA Link
03/2022 - 10/2005
10Biomarkers (Surrogate Marker)IBA
01/2024 - 04/2002
8LeptinIBA
01/2024 - 01/2013
8AntioxidantsIBA
02/2023 - 01/2006
8Ezetimibe (Zetia)FDA Link
01/2017 - 06/2008
7Triglycerides (Triacylglycerol)IBA
08/2023 - 10/2010
7EnzymesIBA
11/2020 - 05/2007
7Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
02/2019 - 01/2007
6AdipokinesIBA
03/2023 - 01/2007
6AdiponectinIBA
04/2022 - 01/2017
6Ursodeoxycholic Acid (Urso)FDA LinkGeneric
12/2018 - 06/2010
5MucinsIBA
10/2023 - 01/2008
5FructoseIBA
06/2022 - 07/2015
5Estrogens (Estrogen)FDA Link
12/2020 - 11/2009
5Silybin (Lagosa)IBA
01/2020 - 05/2012
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
02/2015 - 06/2010
4CytokinesIBA
01/2024 - 03/2010
4Phospholipids (Phosphatides)FDA LinkGeneric
01/2023 - 01/2006
4ColchicineFDA LinkGeneric
02/2020 - 12/2013
4Transaminases (Aminotransferases)IBA
02/2020 - 01/2006
4Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2018 - 08/2008
3BilirubinIBA
10/2023 - 05/2011
3Environmental Pollutants (Pollutants, Environmental)IBA
01/2023 - 12/2014
3MicellesIBA
01/2023 - 06/2008
3Hormones (Hormone)IBA
11/2022 - 07/2016
3SugarsIBA
11/2021 - 01/2019
3Reactive Oxygen Species (Oxygen Radicals)IBA
05/2021 - 10/2007
3Nonesterified Fatty Acids (NEFA)IBA
05/2021 - 01/2007
3Estrogen ReceptorsIBA
12/2020 - 09/2015
3CarbohydratesIBA
11/2020 - 10/2014
3Oleic Acid (Oleate)IBA
01/2020 - 07/2016
3Choline (Choline Chloride)IBA
01/2020 - 10/2007
3C-Reactive ProteinIBA
01/2020 - 08/2016
3PalmitatesIBA
01/2020 - 07/2016
3Lipoproteins (Lipoprotein)IBA
01/2019 - 01/2007
3Therapeutic UsesIBA
11/2017 - 02/2015
3Thiobarbituric Acid Reactive SubstancesIBA
01/2017 - 12/2006
3ThioredoxinsIBA
01/2013 - 10/2005
3Ribavirin (Virazole)FDA LinkGeneric
01/2006 - 05/2004
3Hemoglobins (Hemoglobin)IBA
01/2006 - 05/2004
2MicronutrientsIBA
04/2024 - 08/2023
2VitaminsIBA
04/2024 - 08/2008
2ZincIBA
04/2024 - 08/2023
2Trace Elements (Biometals)IBA
10/2023 - 08/2023
2Glucose (Dextrose)FDA LinkGeneric
10/2023 - 01/2013
2Tryptophan (L-Tryptophan)FDA Link
10/2023 - 01/2023

Therapy/Procedure

37Therapeutics
04/2024 - 05/2004
9Cholecystectomy
10/2023 - 08/2014
6Bariatric Surgery
02/2024 - 08/2014
5Liver Transplantation
03/2023 - 01/2005
4Ligation
03/2023 - 02/2007
4Laparoscopic Cholecystectomy
01/2017 - 06/2010
3Mediterranean Diet
07/2022 - 02/2020
3Length of Stay
01/2022 - 08/2011
3Total Parenteral Nutrition
11/2020 - 12/2018